Successful treatment of a patient with a thymoma and pure red-cell aplasia with octreotide and prednisone

New England Journal of Medicine

Volumn 336, Issue 4, 1997, Pages 263-265

  Palmieri, Giovannella ^a,c   Lastoria, Secondo ^b   Colao, Annamaria ^a   Vergara, Emilia ^b   Varrella, Paola ^b   Biondi, Edoardo ^a   Selleri, Carmine ^a   Catalano, Lucio ^a   Lombardi, Gaetano ^a   Bianco, Angelo Raffaele ^a   Salvatore, Marco ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; OCTREOTIDE; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; ERYTHROCYTE APLASIA; FEMALE; HUMAN; INOPERABLE CANCER; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; THYMOMA; TREATMENT OUTCOME; TUMOR SCINTISCANNING;

ANTINEOPLASTIC AGENTS, HORMONAL; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; MIDDLE AGED; OCTREOTIDE; PREDNISONE; RED-CELL APLASIA, PURE; THYMOMA; THYMUS NEOPLASMS;

EID: 0031012796     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199701233360405     Document Type: Article

References (23)

1. Park HS, Shin DM, Lee JS, et al. Thymoma: a retrospective study of 87 cases. Cancer 1994;73:2491-8.
2. Quintanilla-Martinez L, Wilkins EW Jr, Choi N, Efird J, Hug E, Harris NL. Thymoma: histologic subclassification is an independent prognostic factor. Cancer 1994;74:606-17.
3. Quintanilla-Martinez L, Wilkins EW Jr, Ferry JA, Harris NL. Thymoma - morphologic subclassification correlates with invasiveness and immunohistologic features: a study of 122 cases. Hum Pathol 1993;24:958-69.
4. Verley JM, Hollmann KH. Thymoma: a comparative study of clinical stages, histological features, and survival in 200 cases. Cancer 1985;55: 1074-86.
5. Goldel N, Boning L, Fredrik A, Holzel D, Hartenstein R, Wilmanns W. Chemotherapy of invasive thymoma: a retrospective study of 22 cases. Cancer 1989;63:1493-500.
6. Souadjian JV, Enriquez P, Silverstein MN, Pepin JM. The spectrum of diseases associated with thymoma: coincidence or syndrome? Ann Intern Med 1974;134:374-9.
7. DeSevilla E, Forrest JV, Zivnuska FR, Sagel SS. Metastatic thymoma with myasthenia gravis and pure red cell aplasia. Cancer 1975;36:1154-7.
8. Krantz SB. Pure red-cell aplasia. N Engl J Med 1974;291:345-50.
9. Dessypris EN. The biology of pure red cell aplasia. Semin Hematol 1991;28:275-84.
10. Masaoka A, Hashimoto T, Shibata K, Yamakawa Y, Nakamae K, Iizuk M. Thymomas associated with pure red cell aplasia: histologic and follow-up studies. Cancer 1989;64:1872-8.
11. Casadevall N, Dupuy E, Molho-Sabatier P, Tobelem G, Varet B, Mayeux P. Autoantibodies against erythropoietin in a patient with pure red-cell aplasia. N Engl J Med 1996;334:630-3.
12. Lastoria S, Vergara E, Varrella P, Acampa W, Palmieri G, Salvatore M. In vivo detection of new neoplastic lesions expressing somatostatin receptors using In-111 octreotide. In: Rao RS, Deo MG, Sanghvi LD, Mittra I, eds. Proceedings XVI International Cancer Congress. Bologna, Italy: Monduzzi, 1994:685-9.
13. Lamberts SWJ, Krenning EP, Reubi JC. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr Rev 1991;12: 450-82.
14. Lamberts SWJ, van der Lely A-J, de Herder WW, Hofland LJ. Octreotide. N Engl J Med 1996;334:246-54.
15. Reubi JC, Waser B, Horisberger U, et al. In vitro autoradiographic and in vivo scintigraphic localization of somatostatin receptors in human lymphatic tissue. Blood 1993;82:2143-51.
16. Selleri C, Sato T, Anderson S, Young NS, Maciejewski JP. Interferon-gamma and tumor necrosis factor-α suppress both early and late stages of hematopoiesis and induce programmed cell death. J Cell Physiol 1995; 165:538-46.
17. Roland AS. The syndrome of benign thymoma and primary aregenerativc anemia: an analysis of forty-three cases. Am J Med Sci 1964;247:719-31.
18. Pollack A, Komaki R, Cox JD, et al. Thymoma: treatment and prognosis. Int J Radiat Oncol Biol Phys 1992;23:1037-43.
19. Hu E, Levine J. Chemotherapy of malignant thymoma: case report and review of the literature. Cancer 1986;57:1101-4.
20. Stewart BW. Mechanisms of apoptosis: integration of genetic, biochemical, and cellular indicators. J Natl Cancer Inst 1994;86:1286-96.
21. Kruman II, Matylevich NP, Beletsky IP, Afanasyev VX, Umansky SR. Apoptosis of murine BW 5147 thymoma cells induced by dexamethasone and gamma irradiation. J Cell Physiol 1991;148:267-73.
22. van Hagen PM, Krenning EP, Kwekkeboom DJ, et al. Somatostatin and the immune and haematopoietic system: a review. Eur J Clin Invest 1994;24:91-9.
23. Reichlin S. Neuroendocrine-immune interactions. N Engl J Med 1993;329:1246-53.